STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 214.34 USD -0.66% Market Closed
Market Cap: 21.2B USD
Have any thoughts about
STERIS plc?
Write Note

STERIS plc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

STERIS plc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
STERIS plc
NYSE:STE
Current Portion of Long-Term Debt
$80m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medtronic PLC
NYSE:MDT
Current Portion of Long-Term Debt
$1.6B
CAGR 3-Years
537%
CAGR 5-Years
1%
CAGR 10-Years
-5%
Trinity Biotech PLC
NASDAQ:TRIB
Current Portion of Long-Term Debt
$2.4m
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

STERIS plc
Glance View

Market Cap
21.2B USD
Industry
Health Care

STERRIS plc is a globally recognized leader in the field of infection prevention, surgical, and critical care solutions, committed to enhancing patient safety and healthcare efficiency. With a rich history spanning over 100 years, the company operates in more than 60 countries, offering a diverse range of products and services tailored to meet the needs of healthcare providers. STERIS’s innovative technologies, including sterilization and disinfection equipment, surgical tables, and integrated surgical suites, position it as a vital partner for hospitals and medical facilities striving to uphold high standards of patient care. This focus on innovation not only drives customer loyalty but also positions the company favorably in an industry that increasingly prioritizes safety and efficiency. For investors, STERIS presents a robust growth trajectory, bolstered by a strategic approach to acquisitions and an expansion into emerging markets. The company has consistently delivered strong financial results, reflecting resilience even amidst industry challenges. With an ongoing commitment to research and development, STERIS is well-positioned to leverage trends in healthcare modernization and increasing demand for infection control solutions. As global healthcare systems adapt to rising patient care standards and regulatory requirements, STERIS’s established reputation and forward-thinking strategies make it an attractive investment opportunity for those looking to capitalize on the evolving landscape of healthcare services.

STE Intrinsic Value
224.78 USD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is STERIS plc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
80m USD

Based on the financial report for Sep 30, 2024, STERIS plc's Current Portion of Long-Term Debt amounts to 80m USD.

What is STERIS plc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
54%

Over the last year, the Current Portion of Long-Term Debt growth was 13%. The average annual Current Portion of Long-Term Debt growth rates for STERIS plc have been 54% over the past three years .

Back to Top